Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-046970
Filing Date
2024-11-14
Accepted
2024-11-14 17:05:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20038675_sc13g.htm SC 13G 50458
  Complete submission text file 0001140361-24-046970.txt   51964
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Subject) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92449 | Film No.: 241464093
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 212-287-6787
Blue Owl Capital Holdings LP (Filed by) CIK: 0001858703 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G